Evidence map›Paper›PMID 25600376›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2016

"It All Depends": A Qualitative Study of Parents' Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11-12 years.

Caitlin E Hansen, Marisol Credle, Eugene D Shapiro, Linda M Niccolai

Abstract read
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Preferences for Sexually Transmitted Infection and Cancer Vaccines in the United States and in China.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Caitlin E HansenDepartment of Pediatrics, Yale School of Medicine, PO Box 208064, New Haven, CT, 06520, USA. caitlin.hansen@yale.edu.
Marisol CredleDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Eugene D ShapiroDepartment of Pediatrics, Yale School of Medicine, PO Box 208064, New Haven, CT, 06520, USA.
Linda M NiccolaiDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Yale University · USYale Cancer Center · US

Funding

Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Yale University Clinical and Translational Science Award ProgramKL2TR000140 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$2.9M
Research Training in Pediatric Infectious DiseasesT32AI007210 · NIAID · YALE UNIVERSITY · PI MURRAY, THOMAS SCOT, SHAPIRO, EUGENE DAVID · 1986 to 2023
$2.6M
Disparities in HPV vaccine completion: Identifying and quantifying the barriersR21CA163160 · NCI · YALE UNIVERSITY · PI NICCOLAI, LINDA M · 2013 to 2014
$406k
NCATS NIH HHS KL2 TR000140NCATS NIH HHS UL1 TR000142NCI NIH HHS R21 CA163160NIAID NIH HHS T32 AI007210NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

Routine vaccination with three doses of human papillomavirus (HPV) vaccine is recommended for adolescent girls and boys at 11 or 12 years of age; however, vaccine uptake remains suboptimal. To understand the reasons why parents may accept or refuse HPV vaccine for their children at age 11 or 12 years, we conducted a qualitative study. Semi-structured interviews were conducted with parents or guardians (n = 45) whose adolescents receive care at an urban, hospital-based primary care practice. Data were analyzed using an iterative thematic approach. We found that many parents expressed high levels of support for HPV vaccine, including a majority who agreed with vaccination at age 11-12 years. Parents recognized that for prevention of consequences of HPV infection, vaccination of their child early in adolescence was desirable conceptually. However, many parents also expressed that in practice, HPV vaccine should be given to adolescents at the onset of sexual activity, a perception that led to preferences to delay administration of HPV vaccine among certain parents. These apparently contradictory views indicate the need for interventions focused on the benefits of vaccination at the recommended ages. Our findings may be useful in providers' discussions with parents about the vaccine, as pediatric and adolescent health care providers have the unique opportunity to educate parents and clarify misconceptions about vaccination.

Indexed as

Decision MakingHealth Knowledge, Attitudes, PracticeAdolescentAdultChildFemaleFollow-Up StudiesHumansMaleMiddle AgedPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesParentsPatient Acceptance of Health CarePerceptionPapillomavirus VaccinesHPVHPV vaccineQualitative

Identifiers

PMID25600376
PMCPMC4508236
OpenAlexW2100966063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.